Deepika Pakianathan's Trading History
| TBPHTheravance Biopharma | Sep 24, 2026 | ― | Uninformative Sell | ― | $0.00 | |
| KPTIKaryopharm Therapeutics | May 26, 2026 | Director | Uninformative Buy | ― | $10.27K | |
| MREOMereo Biopharma Group Plc | Aug 23, 2024 | Director | Uninformative Buy | 151.12K | $0.00 | |
| CALACalithera Bio | Jan 31, 2023 | ― | Informative Sell | 46.11K | $0.00 | |
| PRDSPardes Biosciences | Dec 28, 2021 | ― | Uninformative Buy | ― | $113.40K | |
| OMEDOncoMed Pharma | Apr 23, 2019 | ― | Uninformative Sell | ― | $0.00 | |
| ALXAAlexza Pharmaceuticals | Jun 21, 2016 | ― | Uninformative Sell | ― | $931.51K | |
| ALDRAlder Biopharmaceuticals | May 13, 2014 | ― | Uninformative Buy | ― | $53.59M |
You May Also Like
Deepika Pakianathan insider profile FAQ
What is the percentage of profitable transactions made by Deepika Pakianathan?
The percentage of profitable transactions made by Deepika Pakianathan is 70%.
What is the average return per transaction made by Deepika Pakianathan?
The average return per transaction made by Deepika Pakianathan is 51.60%.
What stocks does Deepika Pakianathan hold?
Deepika Pakianathan holds: KPTI, TBPH, ALDR, MREO, PRDS, ALXA, OMED, CALA stocks.
What was Deepika Pakianathan's most profitable transaction?
Deepika Pakianathan’s most profitable transaction was an Informative Buy of ALDR stock on May 13, 2014. The return on the trade was 241.70%.
What is Deepika Pakianathan's role in Karyopharm Therapeutics?
Deepika Pakianathan's role in Karyopharm Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.